Tensive
tensive.com
Actively hiring
Biomedical Engineering
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Grants
$4.8M
3 grants · CORDIS
Backers
1
CDP Venture Capital
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 27%
of 133.2M domains by links, Common Crawl
Funding rounds
Backed byfrom the funds' portfolios and accelerator catalogs
CDP Venture Capital Similar startupsby what they do, their industry and backers
SQIM - The Material Innovation company biofabricating biomaterials grown from mycelium through fungal fermentation, valorising waste and…
Nyctea Tech is advancing life science through innovative biotechnology solutions, combining cutting-edge research with practical…
Meet DotX Automation! A dynamic team of three passionate PhD students, each with a strong background in robotics, engineering, and computer…
Deemea revolutionizes biomedical research with its AI-driven platform, empowering clinical operators to efficiently navigate and interpret…
Where innovation roots. Molecular Horizon is an innovative startup founded in 2017 and based in Bettona (PG), green heart of Italy.
Phylo is an applied research lab dedicated to studying agentic intelligence to accelerate discoveries for every biomedical scientist.
News
Breast implant alternative startup Tensive receives €20 million EIB loan to advance REGENERA
Milan-based MedTech startup Tensive, the developer of REGENERA/SOFTAG bioresorbable scaffolds for breast reconstruction and tissue marking, has recieved a loan of €20 million in order to fund research and development, clinical studies, CE marking, manufac
Read more
Report
Tensive Secures Up To €20 Million EIB Financing To Commercialize Bioresorbable Breast Implant
Tensive has signed a convertible loan agreement with the European Investment Bank for up to €20 million to advance development, regulatory approval, manufacturing scale-up and commercialization of its REGENERA bioresorbable breast implant.
Read more
Report
Medtech, Tensive ottiene 20 milioni di venture debt dalla Bei per protesi al seno all'avanguardia MilanoFinanza News
Le risorse sono fornite con un finanziamento convertibile. I biomateriali avanzati sono destinati a pazienti oncologiche. Fase clinica in corso: prime autorizzazioni previste nel 2027.
Read more
Report
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as T...
Read more
Report
Tensive publishes positive interim pivotal clinical data showing REGENERA supports natural breast reconstruction in Updates in Surgery
Advanced biomaterial device designed for use in lumpectomy surgeries Interim results from the first 25 of 94 patients at 6 months follow upConfirms REGENERA is safe and biocompatible as breast tissue replacement 100% of patients completed adjuvant whole-b
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Milan
Italy
HQ
[email protected]
Via Timavo, 34 20124 Milano (Italy)